Schedule 13G ownership disclosure
NAVIDEA BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 63937X202
Event date: 2023-06-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.7300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-077055
- Form type
- SC 13G
- Filer
- Bain Irwin Allen
- CIK
- CIK 1949247
- Filed
- Jun 30, 2023
- Reporting period
- Jun 19, 2023
- Description
- Schedule 13G beneficial ownership